Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.

Goodman AD, Bethoux F, Brown TR, Schapiro RT, Cohen R, Marinucci LN, Henney HR 3rd, Blight AR; MS-F203, MS-F204, and Extension Study Investigators..

Mult Scler. 2015 Sep;21(10):1322-31. doi: 10.1177/1352458514563591.

2.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

3.

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.

Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators..

J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012.

PMID:
20236661
4.

GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.

Goodman AD, Rossman H, Bar-Or A, Miller A, Miller DH, Schmierer K, Lublin F, Khan O, Bormann NM, Yang M, Panzara MA, Sandrock AW; GLANCE Investigators..

Neurology. 2009 Mar 3;72(9):806-12. doi: 10.1212/01.wnl.0000343880.13764.69.

5.

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.

Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F203 Investigators..

Lancet. 2009 Feb 28;373(9665):732-8. doi: 10.1016/S0140-6736(09)60442-6.

PMID:
19249634
6.

Really, most SINCERELY dead: policy and procedure in the diagnosis of death by neurologic criteria.

Keilson M.

Neurology. 2004 Dec 28;63(12):2458-9; author reply 2458-9. No abstract available.

PMID:
15623740
7.

Symmetrical cerebral metastasis presenting with bilateral upper extremity weakness.

Wilck EJ, Gerard PS, Keilson M, Bashevkin M, Lieberman J.

J Neuroimaging. 1996 Oct;6(4):254-6.

PMID:
8903082
8.

Central pontine myelinolysis with complete recovery.

Keilson MJ, Drexler E, Miller AE, Bruining K.

J Neuroimaging. 1994 Jan;4(1):47-8. No abstract available.

PMID:
8136581
9.

Apneic oxygenation in apnea tests.

Keilson MJ.

Arch Neurol. 1991 Aug;48(8):789-90. No abstract available.

PMID:
1898250
10.

A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, Spada V, Weiss W, Appel S, Rolak L, et al.

Neurology. 1991 Apr;41(4):533-9.

PMID:
2011253
11.

Electrocardiographic changes during electrographic seizures.

Keilson MJ, Hauser WA, Magrill JP.

Arch Neurol. 1989 Nov;46(11):1169-70.

PMID:
2818251
12.

Determining death.

Keilson MJ, Rosner F, Tendler MD, Schachter H, Soloveichik A, Zwiebel CD.

J Halacha Contemporary Society. 1989 Spring;17:7-68. No abstract available.

PMID:
11650852
13.

Clinical experience with COP-1 in multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V, et al.

Neurology. 1988 Jul;38(7 Suppl 2):66-9.

PMID:
3290717
14.

EEG and brain death determination in children.

Alvarez LA, Moshé SL, Belman AL, Maytal J, Resnick TJ, Keilson M.

Neurology. 1988 Feb;38(2):227-30.

PMID:
3340284
15.

EEG monitoring.

Keilson MJ.

Neurology. 1987 Dec;37(12):1889. No abstract available.

PMID:
3683890
16.

ECG abnormalities in patients with epilepsy.

Keilson MJ, Hauser WA, Magrill JP, Goldman M.

Neurology. 1987 Oct;37(10):1624-6.

PMID:
3658168
17.

Ambulatory cassette EEG in absence epilepsy.

Keilson MJ, Hauser WA, Magrill JP, Tepperberg J.

Pediatr Neurol. 1987 Sep-Oct;3(5):273-6.

PMID:
3149472
18.

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V, et al.

N Engl J Med. 1987 Aug 13;317(7):408-14.

PMID:
3302705
19.

Left-handedness in dementia.

Drexler ED, Miller AE, Keilson MJ.

Neurology. 1984 Dec;34(12):1622-3. No abstract available.

PMID:
6504341
20.

The effectiveness of time-limited psychotherapy in a university counseling center.

Keilson MV, Dworkin FH, Gelso CJ.

J Clin Psychol. 1979 Jul;35(3):631-6.

PMID:
573763
Items per page

Supplemental Content

Loading ...
Support Center